Previous close | 2.8000 |
Open | N/A |
Bid | 3.5000 |
Ask | 4.3000 |
Strike | 7.50 |
Expiry date | 2024-05-17 |
Day's range | 2.8000 - 2.8000 |
Contract range | N/A |
Volume | |
Open interest | 20 |
NASHVILLE, Tenn., May 02, 2024--Revance to Release First Quarter 2024 Financial Results on Thursday, May 9, 2024
NASHVILLE, Tenn., April 12, 2024--Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
Key Insights Institutions' substantial holdings in Revance Therapeutics implies that they have significant influence...